DFW Capital Partners announced today that it has held a final closing on DFW Capital Partners IV, L.P., an investment partnership dedicated to making control investments in lower-middle market service companies. DFW IV is capitalized with $162.5 million in commitments from institutional and select individual investors, as well as a significant commitment from the General… Read more »
DFW Capital Partners announced today that it has completed the sale of its portfolio company, SoftWriters Holdings, Inc. to an affiliate of TA Associates, a leading global private equity firm focused on technology, healthcare and service businesses. DFW originally invested in Pittsburgh-based SoftWriters in 2009, leading a management recapitalization of the business from its founding… Read more »
DFW Capital Partners announced today that on August 26, 2013 it completed an equity investment in the parent entity of Sebela International, Ltd and Sebela Pharmaceuticals, Inc. (“Sebela”), a newly-formed specialty pharmaceutical acquisition and licensing platform. Joining DFW in the equity investment was Sebela’s executive management team, members of which had previously led a former… Read more »
DFW Capital Partners is pleased to announce that its portfolio company Meta Pharmaceutical Services, LLC. (‘Meta’), a leading provider of outsourced marketing services to the pharmaceutical industry, has merged with NexGen RxMarketing, LLC (“NexGen”). To facilitate the transaction, DFW invested growth capital in the form of preferred equity, and raised senior and subordinated debt financing. … Read more »
Information Innovators Inc. (‘Triple-I’), a professional Information Technologies services portfolio company of DFW Capital Partners, today announced the acquisition of GoldBot Consulting Inc. (‘GoldBot’), a firm known for its DoD/IC community acclaimed geospatial predictive technology, data mining, and information analytics. The acquisition is intended to significantly strengthen and expand Triple-i’s solutions portfolio and IT offerings… Read more »
DFW Capital Partners announced today that it has closed on a growth investment in Covenant Surgical Partners, Inc. (“Covenant”), a leading acquirer and operator of single and limited-specialty ambulatory surgical centers (“ASCs”) throughout the United States. DFW sourced and led the transaction, partnering with PineBridge Investments and co-investors to acquire a majority interest in Covenant… Read more »
DFW Capital Partners announced today that on June 19, 2012, it completed an equity investment in Vidara Therapeutics (“Vidara”), a newly-formed specialty pharmaceutical acquisition and licensing platform. Joining DFW in the equity investment was Vidara’s executive management team, members of which had previously led a former DFW portfolio company, Alaven Pharmaceutical, through significant growth and… Read more »
DFW Capital Partners announced today the sale of Northeast Dental Management (“NEDM”). NEDM is a leading dental practice management company serving the New Jersey, New York, Pennsylvania and Virginia markets. Terms of the transaction were not disclosed. Based in Paramus, New Jersey, NEDM offers a full suite of management services to dental practices located in… Read more »
DFW Capital Partners announced today that it has completed the sale of its portfolio company, Vigilant Safety Group, which includes its operating subsidiary Copernicus Group IRB, to an affiliate of Arsenal Capital. DFW originally invested in Raleigh, NC-based Vigilant in 2008, supporting a control recapitalization of the company. In connection with its investment, DFW teamed… Read more »
DFW Capital Partners announced today that on March 26, 2012, it made an equity investment in Information Innovators, Inc. (“Triple-I”), a leading provider of IT services to agencies of the U.S. federal government. DFW invested in preferred equity, and raised senior and subordinated debt financing, to facilitate a recapitalization of the company. DFW was joined… Read more »